• Home > Mabome
  • Technology


    Mabomics™ (monoclonal antibody omics) develops monoclonal antibodies for thousands of expressed proteins in a proteome (biological sample). A protein sample (for example, plasma; or a tissue; or a cellular organelle) is processed to produce protein and peptide fractions as immunogens. A set of proprietary mouse monoclonal antibody technologies is employed to produce 10,000-100,000 individual mouse hybridomas to cover a significant portion (typically 30-70%) of the proteome. Thus produced Mabomics™ libraries have broad applications in differential proteomics and reagent development.